Insider Trading History of Connealy Pamela Ann

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Connealy Pamela Ann since 2023. This trader's CIK number is 1796310. At the time of last reporting, Connealy Pamela Ann was the CFO & COO of Pyxis Oncology, Inc.. (stock ticker symbol PYXS). Also see all insider trading activities at Pyxis Oncology, Inc..

Note that in the past Connealy Pamela Ann also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Orchestra Biomed Holdings, Inc. (OBIO) by Connealy Pamela Ann

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 OBIO 0 $0 0 $0 758 $0

Yearly summary of insider trading at Pyxis Oncology, Inc. (PYXS) by Connealy Pamela Ann

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 PYXS 88,850 $175,923 0 $0 0 $0
2023 PYXS 31,426 $55,563 0 $0 0 $0


Insider trading activities at 2 companies by Connealy Pamela Ann:

1. Orchestra Biomed Holdings, Inc. (OBIO)

2. Pyxis Oncology, Inc. (PYXS)

Table 1. Insider trading of Orchestra Biomed Holdings, Inc. (OBIO) by Connealy Pamela Ann

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-04-12 OBIO Option Ex 758 .00 0

Table 2. Insider trading of Pyxis Oncology, Inc. (PYXS) by Connealy Pamela Ann

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-11-26 PYXS Buy 88,850 1.98 175,923
2023-09-28 PYXS Buy 8,000 1.87 14,960
2023-09-27 PYXS Buy 6,426 1.85 11,868
2023-09-25 PYXS Buy 12,000 1.67 20,040
2023-09-22 PYXS Buy 5,000 1.74 8,695

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Connealy Pamela Ann (CFO & COO of Pyxis Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.